Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

IAVI salutes the confirmation of John Nkengasong as head of PEPFAR

May 6, 2022

Nkengasong was a founding leader of PEPFAR and served on IAVI’s board of directors.

Read more

Scientific Publications

A neutralizing antibody target in early HIV-1 infection was recapitulated in rhesus macaques immunized with the transmitted/founder envelope sequence

Read more

Scientific Publications

HIV prevention in a time of COVID 19 A report from the HIVR4P Virtual conference 2021

Read more

Scientific Publications

A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant

Read more

IAVI Report

From the editor — a new IAVI Report

April 27, 2022

After 25 years of IAVI Report, we’re making a few changes. In 2020, life changed for many across the globe. As SARS-CoV-2 began its deadly march through humankind, countries entered lockdown, offices and schools closed, and many of us who weren’t on the so-called front lines of the pandemic were largely sheltered within our homes.…

Read more

IAVI Report

The future of mRNA-based HIV vaccines is about more than speed

April 27, 2022

Right now in vaccine research, mRNA has the momentum. For HIV, there are currently several formulations of experimental vaccines in early-stage human clinical trials. Apart from some overlap in strategy, they have one main thing in common — they rely on mRNA. This trend reflects the intense overall interest in mRNA-based vaccine development, given its…

Read more

IAVI Report

Jon Cohen on writing about COVID-19 and why we must prepare now for the next public health crisis

April 27, 2022

A conversation with Jon Cohen about what made writing about this pandemic different and what stories are still to be told.

Read more

Scientific Publications

Measles immunity gap among reproductive-age women participating in a simulated HIV vaccine efficacy trial in Zambia

Read more